Tag | Content |
---|
EnhancerAtlas ID | HS139-14997 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr13:46933770-46935570 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESR1 | MA0112.3 | chr13:46934028-46934045 | TAGGTCATTTTGACCTG | - | 6.77 | ESRRB | MA0141.3 | chr13:46935548-46935559 | TCAAGGTCAAT | + | 6.02 | Esrra | MA0592.2 | chr13:46935547-46935558 | TTCAAGGTCAA | + | 6.14 | PPARG | MA0066.1 | chr13:46934027-46934047 | GTAGGTCATTTTGACCTGGA | + | 6.04 | PPARG | MA0066.1 | chr13:46934026-46934046 | AGTAGGTCATTTTGACCTGG | - | 6.54 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_11021 | chr13:46931570-46935444 | CD20 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr13 | 46933914 | 46934270 | chr13 | 46934926 | 46934982 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH13I046359 | chr13 | 46933430 | 46934668 |
|
Enhancer Sequence | ATAAGACATA AAATGATTTA GGAACAACTT AAGCATATTT CAAAGAATTT AAATTAAAGA 60 AACATCTAAA TGTATTTCCA ACATTAAAAT TTACCATGAA AAATTAACAG TGCTTTTAAC 120 TGAACTAAAG GGCATACCAA GAGCCCTCCA CATCTCTAAA GCCATCTGCA AGAGAATTGC 180 TTTAAACACC ACCCAGATGA GATCACTTTT CTTAGTATTT TTAGTTCATT TATTTCCAGA 240 CTTCAAATTT ACTGTAAGTA GGTCATTTTG ACCTGGAATG CATTTATGAA TAGCAGAAGC 300 CTCACCCCTC TTAGTCAACA GACTGACAAA TGCTACCAAT CAGAACCCCT ATCATTATTA 360 GTCTTCCCCA GAAACAGCTC TATTAAGACC TTTCCCCTTG CTTACAAATG TTCAGTGCCT 420 CCCCGCTGAA CCACTGGACT TTCCTACTGT CATTTAAAAT CCAAACTTCT CAGCTGGGTG 480 CAGTGGCTCA TGCTTGTTTT CCTAGCACTT TGGGAGGCCG AGGTGGGTGG ATCACTTGAG 540 GTCAGGAGTT TGAGACCAGC CTGGCCAACA TAGTGAAACC CTGTCTCTAC TAAAAGTACA 600 AAAGTTAGCC AGAAATTGCT TGAACCCAGG AGGTGGAGGT TGCAGTGAGT CGAGCTTGTG 660 CCACTGCACT CCACCCTGGG CAACAGAGTG AGACTCCATC TTAAAAAATA AATAAAATAA 720 AATAAAATAA AATCCAAACT TCTCAAATTA GCATTCTACA TCCTCCACAA TTTGGCTACT 780 ATCATTCAAA CCTTATTTCC ATAAAGAACA ACCTCTCAGA CACAAATACT CACAAACGGG 840 TATTATCCAA CCGCAGCGAA TCACTCTGCT CAACGGCATA GCATGCCCCT CCACTTTTGC 900 TGCAGCTCCC CTTTGCCAAG AACGTCCTCC CCCAACCTTT CTACCTGCCA CAGTTCTGGC 960 CAGCCCAATA CTTAGCTCAA GTTCTGAAAT CTGCAGTCAG CCTTCCTAAG TTCCCCTGGT 1020 AAAATTAAAC ACTCCTTCCT CTGCACTTCG AGGGCATTTT CCCTACCCCT GTTTTAGCCT 1080 TTGTCATAAT GTTCTCTACC CTCAGAAGGC TGCTTGCTCT CTGACAGCAG TGAGCAGTGT 1140 GTTCCATGAG GGAACCAACA TGTACTTTCC AATGAGGCAG CCTGGGCATG ACTCCTGCTT 1200 CACAGCTGAC CAGCCCTGCT GGGAGGCTGG GCCCACCACT TAAAAATAAA AATAAGGACA 1260 GCCTCTACCT AACAGGATAC TTATGAGGAT TAAAATGTGG ACTGCTGGCC GGGCACGGTG 1320 GCTCAGGCCT ATAATCCTAG CACTTTGAGA GGCCAAGGTG GGCAGATCAC TTGAGGTCAG 1380 GAGTTGGAAA CCAGCTGGCC AGCATGGTGA AACCCTGTCT CTACTAAAAA TACAAAAAAG 1440 TTAGCTGGGC GTGGTGGCGT GCGCCTGTAG TCCCAGCTAC TTGGGAGGCT GAGGCAGGAG 1500 AATCGCTTGA ACCCAGGAAG CGGAGGTTGC AGTGAGCTGA GATTGCGCCA CTGCACTCCA 1560 GCCTGGGTGA CAGAGCAAGA ATCCGTCTCA AAAAAATTAA TAAATAAAAT AAAATAATGT 1620 GGACTGCTGA GCACAGTCTC TGGTACACAA TAAGTACTCA ACACATGCCA GTTTCCTCAT 1680 TCATTTTGAG TCTCCCCTAA TATCCAGTGA CCATACAAGG AAAGACAAAT GTTTAAAGTG 1740 AACAGGGCAG GCAAAATGAG GATTTAGGAA CTTTCAATTC AAGGTCAATT TTTTTTGATA 1800
|